Works matching IS 02770008 AND DT 2022 AND VI 42 AND IP 7
Results: 9
Poor tolerability of cystic fibrosis transmembrane conductance regulator modulator therapy in lung transplant recipients.
- Published in:
- Pharmacotherapy, 2022, v. 42, n. 7, p. 580, doi. 10.1002/phar.2710
- By:
- Publication type:
- Article
Early combination therapy with immunoglobulin and steroids is associated with shorter ICU length of stay in Multisystem Inflammatory Syndrome in Children (MIS‐C) associated with COVID‐19: A retrospective cohort analysis from 28 U.S. Hospitals.
- Published in:
- Pharmacotherapy, 2022, v. 42, n. 7, p. 529, doi. 10.1002/phar.2709
- By:
- Publication type:
- Article
Reduced risk of NSAID‐Induced adverse events with concomitant use of misoprostol (MICRO study).
- Published in:
- Pharmacotherapy, 2022, v. 42, n. 7, p. 540, doi. 10.1002/phar.2708
- By:
- Publication type:
- Article
Safety and effectiveness of NMDA receptor antagonists for depression: A multidisciplinary review.
- Published in:
- Pharmacotherapy, 2022, v. 42, n. 7, p. 567, doi. 10.1002/phar.2707
- By:
- Publication type:
- Article
Myocardial infarction associated with erenumab: A case report.
- Published in:
- Pharmacotherapy, 2022, v. 42, n. 7, p. 585, doi. 10.1002/phar.2706
- By:
- Publication type:
- Article
Evaluating adherence to concomitant diabetes, hypertension, and hyperlipidemia treatments and intermediate outcomes among elderly patients using marginal structural modeling.
- Published in:
- Pharmacotherapy, 2022, v. 42, n. 7, p. 518, doi. 10.1002/phar.2705
- By:
- Publication type:
- Article
Safety and efficacy of cefiderocol for off‐label treatment indications: A systematic review.
- Published in:
- Pharmacotherapy, 2022, v. 42, n. 7, p. 549, doi. 10.1002/phar.2704
- By:
- Publication type:
- Article
Corrigendum.
- Published in:
- 2022
- Publication type:
- Correction Notice
Issue Information.
- Published in:
- Pharmacotherapy, 2022, v. 42, n. 7, p. 515, doi. 10.1002/phar.2421
- Publication type:
- Article